Editor - Helen L Reeves | Northern Institute for Cancer Research | 4448
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1384

Journal of Gastrointestinal & Digestive System received 1384 citations as per Google Scholar report

Journal of Gastrointestinal & Digestive System peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Helen L Reeves

Helen L Reeves
Helen L Reeves
Northern Institute for Cancer Research
Newcastle University
Tel. 0191-246-4423


Helen L Reeves is an academic gastroenterologist based within the Northern Institute for Cancer Research at Newcastle University Medical School.  As a clinician she is the lead for the care of North East UK patients with hepatocellular cancer.  Her research interests lie within the pathobiology of chronic liver disease and hepatopancreatobiliary cancers.  Broadly, her aim is to create and maintain the environment for successful collaboration and  translational research. Specific topics include the involvement of the tumour suppressor gene, KLF6, in non-alcoholic fatty liver disease and cancer; the role of sulfatase 2 as both a biomarker and a therapeutic target, and the roles of DNA repair in HPB cancer progression.

Research Interest

Helen L Reeves research interests include Clinical staging and management of patients with Hepatocellular cancer, Biomarkers of HPB disease, The metabolic syndrome and non-alcoholic fatty liver disease, The roles of the tumour suppressor gene KLF6 in chronic disease and cancer, SULF2 in HPB disease, DNA repair in HPB disease